Home Newsfeeds Wolfe Research Downgrades ConocoPhillips to Peer Perform

Wolfe Research Downgrades ConocoPhillips to Peer Perform

Wolfe Research analyst Sam Margolin downgrades ConocoPhillips (NYSE:COP) from Outperform to Peer Perform.

byBenzinga Newsdesk

January 12, 2023

1 minute read

Wolfe Research analyst Sam Margolin downgrades ConocoPhillips (NYSE:COP) from Outperform to Peer Perform.

Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon

By Vandana Singh

January 19, 10:52 AM

Surmodics Inc (NASDAQ:SRDX) has received a letter from the FDA related to its premarket approval (PMA) application for the SurVeil drug-coated…

SRDX

Clinical Triumph: MEI Pharma’s Voruciclib Demonstrates Encouraging Activity in AML Patients

By Vandana Singh

May 23, 2:49 PM

MEI Pharma Inc (NASDAQ: MEIP) announced an update to the Phase 1 study of voruciclib, an orally administered cyclin-dependent kinase 9 inhibitor, in patients with relapsed and refractory (R/R) acute myeloid leukemia (AML)

ABBV

News

International Monetary Fund Gourinchas Says A 5.5% U.S. Unemployment Rate Would Be A ‘Fairly Benign Outcome’ In Exchange For Bringing Inflation Back To 2% Target; Projects U.S. Unemployment Rate Will Rise 2 Percentage Points Over 2023 And 2024

By Benzinga Newsdesk

October 11, 4:38 PM

- Reuters

SPY

Global
News

Abbott’s FreeStyle Libre 3 Integrated With Automated Insulin Delivery System mylife Loop In Germany

By Benzinga Newsdesk

December 21, 10:09 AM

First automated insulin delivery (AID) system in the world to work with Abbott's FreeStyle Libre® 3 sensor Automated process streamlines and improves daily diabetes management for people who are on

ABT

Wolfe Research Downgrades ConocoPhillips to Peer Perform

Related Posts

Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon

Clinical Triumph: MEI Pharma’s Voruciclib Demonstrates Encouraging Activity in AML Patients

International Monetary Fund Gourinchas Says A 5.5% U.S. Unemployment Rate Would Be A ‘Fairly Benign Outcome’ In Exchange For Bringing Inflation Back To 2% Target; Projects U.S. Unemployment Rate Will Rise 2 Percentage Points Over 2023 And 2024

Abbott’s FreeStyle Libre 3 Integrated With Automated Insulin Delivery System mylife Loop In Germany